Mespere LifeSciences is a high tech medical company based in Waterloo, Ontario. Mespere is devoted to developing non-invasive solutions to reduce the need for invasive procedures. Mespere has successfully developed a number of breakthrough products in the field of hemodynamic monitoring, such as the world’s first non-invasive and continuous central venous pressure (VENUS 2000 CVP) and jugular venous oximetry (VO 100) monitoring systems. Mespere has successfully completed a number of validation, usability, and outcome studies with key opinion leaders and research institutions globally. The products have obtained FDA and Health Canada approval, a CE mark, and Mespere is ISO 13485 certified.